BRCA1 and neoplasm: Recent advances of comprehensive genomic analysis enable us to identify the genomic alterations in GC.16BRCA1/2 mutations were shown in the subset of GC tumor tissues; however, the association between germline BRCA1/2 mutations and familial predisposition to GC were not fully understood.